Amneal Pharmaceuticals, Inc.
AMRX
Revenue
814.32M
▲29.81M▲3.80%
3 Months ChangeAssets
3.68B
▲78.41M▲2.18%
3 Months ChangeLiabilities
0.00
0.000.00%
3 Months ChangeFree Cash Flow
-5.75M
▲7.85M▲57.72%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-27
Form 8-K
ID: 0001723128-26-000008
2026-02-03
Form 8-K
ID: 0001628280-26-004738
2026-01-28
Form 8-K
ID: 0001628280-26-003842
2026-01-13
Form 8-K
ID: 0001723128-26-000003
2025-11-06
Form 10-Q
ID: 0001723128-25-000062
2025-10-30
Form 8-K
ID: 0001723128-25-000059
2025-08-07
Form 10-Q
ID: 0001723128-25-000047
2025-08-05
Form 8-K
ID: 0001723128-25-000037
2025-08-01
Form 8-K
ID: 0000950103-25-009701
2025-07-24
Form 8-K
ID: 0000950103-25-009253